AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Collegium Pharmaceutical
COLL
SilverCrest Metals
SILV
Enerpac Tool
EPAC
Halozyme Therapeutics
HALO
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | 533.33%494M | 301.34%598M | 353.57%127M | -35.65%-156M | -568.75%-75M | 104.96%78M | 127.54%149M | 119.05%28M | 3.36%-115M | 102.09%16M |
Deferred tax | 779.17%211M | ---- | ---- | ---- | ---- | 116.44%24M | ---- | ---- | ---- | ---- |
Other non cash items | --54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Change In working capital | 2,187.88%755M | -32.36%1.16B | -30.98%-482M | 940.45%748M | 45.25%-669M | 117.19%33M | 41.49%1.71B | 47.05%-368M | 9.18%-89M | -100.66%-1.22B |
-Change in other current assets | ---- | ---- | -30.98%-482M | 940.45%748M | ---- | ---- | ---- | 47.05%-368M | 9.18%-89M | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 127.07%2.33B | 9.22%2.17B | 387.10%89M | 1,631.25%831M | 22.48%-755M | 626.67%1.03B | 29.25%1.98B | 94.95%-31M | 125.53%48M | -4.96%-974M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Net PPE purchase and sale | -63.84%-657M | -52.47%-247M | -38.71%-172M | -41.05%-134M | -420.00%-104M | -24.15%-401M | -57.28%-162M | -202.44%-124M | -28.38%-95M | 80.95%-20M |
Net intangibles purchase and sale | -11.75%-485M | -7.59%-156M | 2.91%-100M | -43.62%-135M | -2.17%-94M | 3.13%-434M | 3.97%-145M | 1.90%-103M | 9.62%-94M | -4.55%-92M |
Net business purchase and sale | -87.72%7M | -10.00%9M | -106.25%-1M | --0 | 0.00%-1M | 242.50%57M | 211.11%10M | 277.78%16M | 260.00%32M | 50.00%-1M |
Net investment purchase and sale | -1,218.75%-211M | -285.71%-27M | -2,450.00%-102M | -3,050.00%-63M | -533.33%-19M | -113.45%-16M | -800.00%-7M | -103.42%-4M | -300.00%-2M | ---3M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -71.48%-1.34B | -38.03%-421M | -79.33%-373M | -110.13%-332M | -93.69%-215M | -15.17%-782M | -16.86%-305M | -593.33%-208M | 18.13%-158M | 43.08%-111M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | -128.49%-261M | -1,880.00%-99M | -120.66%-100M | -114.71%-73M | -97.66%11M | -12.18%916M | -111.63%-5M | 2.98%484M | ---34M | -11.13%471M |
Net common stock issuance | -263.64%-40M | --0 | --0 | -263.64%-40M | ---- | ---11M | --0 | --0 | ---11M | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -164.33%-478M | -260.98%-148M | -132.95%-143M | -75.58%-151M | -108.26%-36M | -12.17%743M | -685.71%-41M | -0.23%434M | 4.44%-86M | -11.74%436M |
Net cash flow | ||||||||||
Beginning cash position | 39.53%3.32B | 29.54%2.2B | 75.27%2.64B | 34.39%2.29B | 39.53%3.32B | -1.74%2.38B | 48.90%1.7B | 11.41%1.5B | -5.22%1.71B | -1.74%2.38B |
Current changes in cash | -48.08%513M | -2.44%1.6B | -318.97%-427M | 277.55%348M | -55.01%-1.01B | 3,628.57%988M | 27.87%1.64B | 193.30%195M | 58.39%-196M | -3.18%-649M |
Effect of exchange rate changes | 70.83%-14M | 237.50%22M | -300.00%-12M | 14.29%-6M | 18.18%-18M | -242.86%-48M | 61.90%-16M | -50.00%-3M | -135.00%-7M | -320.00%-22M |
End cash Position | 15.04%3.82B | 15.04%3.82B | 29.54%2.2B | 75.27%2.64B | 34.39%2.29B | 39.53%3.32B | 39.53%3.32B | 48.90%1.7B | 11.41%1.5B | -5.22%1.71B |
Free cash flow | 771.85%1.18B | 5.13%1.76B | 29.07%-183M | 489.36%549M | 16.70%-953M | 113.31%135M | 31.09%1.68B | 67.91%-258M | 61.58%-141M | -1.87%-1.14B |
Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |